Enact Holdings (NASDAQ: ACT) holder to sell 20,024 shares

Rhea-AI Filing Summary

ACT filed a notice of proposed sale of common stock. The filing lists 20,024 shares of common stock to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an approximate aggregate market value of $991,687.66, and notes 137,483,671 shares outstanding. The shares come from multiple restricted stock vesting compensation awards between September 2024 and March 2025.

Key Figures

Shares proposed to be sold: 20,024 shares Approximate aggregate market value: $991,687.66 Shares outstanding: 137,483,671 shares +4 more

7 metrics

Shares proposed to be sold 20,024 shares Common stock listed for sale on NASDAQ in Form 144

Approximate aggregate market value $991,687.66 Value of the 20,024 ACT common shares proposed to be sold

Shares outstanding 137,483,671 shares Total ACT common shares outstanding referenced in the notice

Vesting lot 1 7,635 shares Restricted stock vesting on 09/15/2024 classified as compensation

Vesting lot 2 2,055 shares Restricted stock vesting on 02/09/2025 classified as compensation

Vesting lot 3 2,493 shares Restricted stock vesting on 02/11/2025 classified as compensation

Largest vesting lot 6,029 shares Restricted stock vesting on 02/24/2025 classified as compensation

Key Terms

Form 144, Restricted Stock Vesting, Approximate aggregate market value, Compensation

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 09/15/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Approximate aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 20024 | 991687.66"

Compensation financial

"7635 | 09/15/2024 | Compensation"

FAQ

What does ACT's Form 144 filing disclose about planned stock sales?

ACT’s Form 144 discloses a proposed sale of 20,024 shares of common stock through Fidelity, with an approximate aggregate market value of $991,687.66. These shares were acquired via restricted stock vesting awards over several dates from September 2024 through March 2025.

How many ACT (ACT) shares are outstanding according to this Form 144?

The Form 144 reports that 137,483,671 shares of ACT common stock are outstanding. This figure provides context for the planned sale of 20,024 shares, showing the proposed sale represents a small portion of total outstanding shares.

What is the approximate market value of the ACT shares covered by this Form 144?

The filing states an approximate aggregate market value of $991,687.66 for the shares proposed to be sold. This value corresponds to the 20,024 shares of ACT common stock listed in the Form 144 for potential sale on NASDAQ.

How were the ACT shares in this Form 144 acquired?

The ACT shares were acquired through restricted stock vesting as compensation from the issuer. The filing lists vesting dates including 09/15/2024, 02/09/2025, 02/11/2025, 02/16/2025, 02/24/2025, and 03/14/2025, each associated with specific share amounts.

What individual restricted stock vesting amounts are disclosed for ACT in this Form 144?

The Form 144 lists vesting-related amounts of 7,635, 2,055, 2,493, 1,746, 6,029, and 66 shares of ACT common stock. These compensation-related lots collectively correspond to the 20,024 shares proposed for sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 03:26 PM Accepted by SEC EDGAR 08/17/2026 - 03:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20024	991687.66	137483671	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2024	Restricted Stock Vesting	Issuer			7635	09/15/2024	Compensation
Common	02/09/2025	Restricted Stock Vesting	Issuer			2055	02/09/2025	Compensation
Common	02/11/2025	Restricted Stock Vesting	Issuer			2493	02/11/2025	Compensation
Common	02/16/2025	Restricted Stock Vesting	Issuer			1746	02/16/2025	Compensation
Common	02/24/2025	Restricted Stock Vesting	Issuer			6029	02/24/2025	Compensation
Common	03/14/2025	Restricted Stock Vesting	Issuer			66	03/14/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)